IL6 and neoplasm: In the subset of tumor-promoting CAFs, iCAFs can participate in immune escape or directly act on pancreatic cancer cells by producing inflammatory cytokines such as IL-6, leukemia inhibitor factor (LIF), and CXCL1 to promote tumor progression [30].